Retained in HIV Care But Not on Antiretroviral Treatment: A Qualitative Patient-Provider Dyadic Study

1. Office of National AIDS Policy, the White House. National HIV/AIDS Strategy for the United States. http://www.whitehouse.gov/sites/default/files/uploads/NHAS.pdf.

2. Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ (2011) The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis 52: 793–800. doi: 10.1093/cid/ciq243 21367734

3. Hall HI, Frazier EL, Rhodes P, Holtgrave DR, Furlow-Parmley C, et al. (2013) Differences in human immunodeficiency virus care and treatment among subpopulations in the United States. JAMA internal medicine 173: 1337–1344. doi: 10.1001/jamainternmed.2013.6841 23780395

4. Hughes AJ, Mattson CL, Scheer S, Beer L, Skarbinski J (2014) Discontinuation of antiretroviral therapy among adults receiving HIV care in the United States. Journal of acquired immune deficiency syndromes 66: 80–89. doi: 10.1097/QAI.0000000000000084 24326608

5. Alfonso V, Bermbach N, Geller J, Montaner JS (2006) Individual variability in barriers affecting people's decision to take HAART: a qualitative study identifying barriers to being on HAART. AIDS Patient Care STDS 20: 848–857. 17192150

6. Turner BJ, Fleishman JA, Wenger N, London AS, Burnam MA, et al. (2001) Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons. J Gen Intern Med 16: 625–633. 11556944

7. Bogart LM, Wagner G, Galvan FH, Banks D (2010) Conspiracy beliefs about HIV are related to antiretroviral treatment nonadherence among african american men with HIV. J Acquir Immune Defic Syndr 53: 648–655. doi: 10.1097/QAI.0b013e3181c57dbc 19952767

8. Bogart LM, Catz SL, Kelly JA, Benotsch EG (2001) Factors influencing physicians' judgments of adherence and treatment decisions for patients with HIV disease. Med Decis Making 21: 28–36. 11206944

9. Loughlin A, Metsch L, Gardner L, Anderson-Mahoney P, Barrigan M, et al. (2004) Provider barriers to prescribing HAART to medically-eligible HIV-infected drug users. AIDS Care 16: 485–500. 15203416

10. Mugavero MJ, Napravnik S, Cole SR, Eron JJ, Lau B, et al. (2011) Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy. Clin Infect Dis 53: 927–935. doi: 10.1093/cid/cir526 21890751

11. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, et al. (2011) Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 365: 493–505. doi: 10.1056/NEJMoa1105243 21767103

12. Reekie J, Gatell JM, Yust I, Bakowska E, Rakhmanova A, et al. (2011) Fatal and nonfatal AIDS and non-AIDS events in HIV-1-positive individuals with high CD4 cell counts according to viral load strata. AIDS 25: 2259–2268. doi: 10.1097/QAD.0b013e32834cdb4b 21918422

13. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.

14. Kurth AE, Mayer K, Beauchamp G, McKinstry L, Farrior J, et al. (2012) Clinician practices and attitudes regarding early antiretroviral therapy in the United States. Journal of acquired immune deficiency syndromes 61: e65–69. doi: 10.1097/QAI.0b013e31826a184c 23183150

15. Van Manen M (1990) Researching Lived Experience. Albany, NY: State University of New York Press.

16. Eisikovits Z, Koren C (2010) Approaches to and outcomes of dyadic interview analysis. Qual Health Res 20: 1642–1655. doi: 10.1177/1049732310376520 20663940

17. Mugavero MJ, Davila JA, Nevin CR, Giordano TP (2010) From access to engagement: measuring retention in outpatient HIV clinical care. AIDS Patient Care STDS 24: 607–613. doi: 10.1089/apc.2010.0086 20858055

18. Sturges JE, and Hanrahan K.J. Comparing telephone and face-to-face qualitative interviewing: a research note. Qualitative Research 4: 107–118.

19. Lekas HM, Siegel K, Leider J (2012) Challenges facing providers caring for HIV/HCV-coinfected patients. Qual Health Res 22: 54–66. doi: 10.1177/1049732311418248 21825278

20. Grimes RM, Grimes DE (2010) Readiness: the state of the science (or the lack thereof). Curr HIV/AIDS Rep 7: 245–252. doi: 10.1007/s11904-010-0056-2 20714831

21. Mead N, Bower P (2000) Patient-centredness: a conceptual framework and review of the empirical literature. Soc Sci Med 51: 1087–1110. 11005395

22. Flickinger TE, Saha S, Moore RD, Beach MC (2013) Higher quality communication and relationships are associated with improved patient engagement in HIV care. Journal of acquired immune deficiency syndromes 63: 362–366. doi: 10.1097/QAI.0b013e318295b86a 23591637

23. Katz IT, Dietrich J, Tshabalala G, Essien T, Rough K, et al. (2015) Understanding treatment refusal among adults presenting for HIV-testing in Soweto, South Africa: a qualitative study. AIDS and behavior 19: 704–714. doi: 10.1007/s10461-014-0920-y 25304330

24. Kleinman A, Benson P (2006) Anthropology in the clinic: the problem of cultural competency and how to fix it. PLoS Med 3: e294. 17076546

25. Shuter J (2008) Forgiveness of non-adherence to HIV-1 antiretroviral therapy. J Antimicrob Chemother 61: 769–773. doi: 10.1093/jac/dkn020 18256112